Medical Device Network on MSN

JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth

"JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth" was originally created and published by Medical ...

How Investors May Respond To DexCom (DXCM) Strong 2025 Revenue Beat And 2026 Growth Outlook

DexCom recently reported preliminary, unaudited results showing fourth-quarter 2025 revenue of about US$1.26 billion and full-year 2025 revenue of roughly US$4.66 billion, both rising at double-digit ...
AOL

Where Will DexCom Be in 5 Years?

Over the past five years, diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has made meaningful progress on several fronts. The company launched new products in the continuous glucose ...

Is DexCom (DXCM) Pricing Justified After Recent Multi Year Share Price Weakness

Wondering whether DexCom's current share price lines up with its underlying worth, or if the market is missing something ...
Fierce Biotech

JPM26: Dexcom's new CEO outlines approach to stop a repeat of G7 supply shortage

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...
Seeking Alpha

Investors Take Note: DexCom Is Back!

DexCom's Q3 performance shows impressive organic growth rates and increased revenue guidance for 2023. The company's strategic focus on international markets and expanding customer bases indicates ...